Media & Resources

NEW YORK, May 13, 2010—In the 27 years since HIV was discovered, scientists have learned a great deal about the virus and how it causes AIDS. Making a vaccine to stop it, however, has proved a greater challenge than anyone could have imagined. Plain good news in this field has been a rarity. So it…

NEW YORK, NY and GAITHERSBURG, MD, April 22, 2010 — The International AIDS Vaccine Initiative (IAVI) and Lentigen today announced a collaboration to design a preventive AIDS vaccine based on Lentigen’s technology. The candidate AIDS vaccine will be devised to safely mimic biological aspects of HIV infection and tested first in pre-clinical studies as part…

NEW YORK, February 1, 2010—The International AIDS Vaccine Initiative (IAVI) is pleased to announce the appointment of David N. Cook as Executive Vice President and Chief Operating Officer. In this role, Cook will lead the senior management team, oversee IAVI’s operations and work closely with IAVI’s CEO Seth Berkley to drive the organization’s strategy for…

The International AIDS Vaccine Initiative (IAVI), Profectus BioSciences Inc. and Ichor Medical Systems announce today the start of a multi-center Phase I trial in Africa to evaluate the safety and immunogenicity of a preventive AIDS vaccine candidate. The trial is sponsored by IAVI and will be conducted in collaboration with Profectus, Ichor and three clinical…

The International AIDS Vaccine Initiative (IAVI) applauds U.S. Secretary of State Hillary Clinton’s powerful, comprehensive speech on lesbian, gay, bisexual and transgender (LGBT) rights at the United Nations Human Rights Council in Geneva on December 6.  “Some have suggested that gay rights and human rights are separate and distinct,” Secretary Clinton said, “but in fact…

On this World AIDS Day, IAVI remembers the women, men and children who have lost their lives to AIDS. We also look ahead to the day when people no longer die because of AIDS, when there are no new cases of HIV, when people no longer experience stigma and discrimination simply because they are living…

NEW YORK, NOVEMBER 1, 2011—The International AIDS Vaccine Initiative (IAVI) announces the appointment to its Board of Directors of Mary Tydings, a Managing Director at Russell Reynolds Associates, one of the world’s largest executive recruiting and assessment firms. Tydings joins a diverse group of 16 directors from 10 countries with backgrounds in finance, vaccinology, international…

The International AIDS Vaccine Initiative (IAVI) congratulates the sponsors of the RTS,S Phase III efficacy trial, who published yesterday initial results showing that the vaccine candidate reduced the risk of clinical malaria and severe malaria by 56% and 47%, respectively, among children aged 5-17 months over the first year following vaccination. This success demonstrates the…